Skip to main content

Elena Andretta

Institutions of which they are part

Research technician
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Elena Andretta

Institutions of which they are part

Research technician
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Projects

Grup de Recerca Emergent (GRE) Childood Cancer & Blood disorders

IP: Lucas Moreno Martín-Retortillo
Collaborators: Luís Gros Subias, Raquel Andreu Vilarroig, Andrea Vilaplana Blanes, Pablo Velasco Puyó, Laura Murillo Sanjuán, Maria Isabel Benitez Carabante, Aroa Soriano Fernández, Guillem Pons Barcons, Jose Miguel Lizcano De Vega, Maria Cristina Díaz de Heredia Rubio, Maria Luz Uría Oficialdegui, Maria Jose Pérez García, Miguel Segura Ginard, M Mar Mañu Pereira, Lorena Valero Arrese, Thaïs Murciano Carrillo, Constantino Sábado Álvarez, Anna Llort Sales, Raquel Hladun Alvaro, Carlota Aguilera Ordoñez, Adria Molero Valenzuela, Júlia Sansa Girona, Gabriela Guillén Burrieza, Laura Alonso Garcia, Idoia Bolinaga Ayala, Josep Roma Castanyer, Sergio Espinosa Gil, Elena Andretta, Amira Idrizovic
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 00638
Duration: 01/01/2022 - 30/06/2025

RHOA signaling in gastric cancer: friend or foe?

IP: -
Collaborators: Nivardo Rodríguez Conde, Manuel Armengol Carrasco, Mª Elena Elez Fernandez, Maria Alsina Maqueda, Stefania Landolfi , Elena Andretta
Funding agency: Asociación Española Contra el Cáncer
Funding: 1015000
Reference: 2015/AECC-GCE/ARANGO
Duration: 01/07/2015 - 30/06/2022

Oncologia Molecular (GRC)

IP: -
Collaborators: Elena Andretta
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding:
Reference: 2014 SGR 1084
Duration: 01/01/2014 - 31/12/2016

Maintenance of the epithelial brush border and colateral cancer

IP: -
Collaborators: Elena Andretta
Funding agency: Instituto de Salud Carlos III
Funding: 324885
Reference: PI12/01095
Duration: 01/01/2013 - 30/06/2017

Related news

The study analyzes the impact of COVID-19 on people with rare red blood cell disorders, identifying risk factors for severe forms of the disease.

The association, once again, has shown its commitment to oncological research with a donation of €19,197 to the Cancer and Hematological Diseases Group for Children at VHIR.

The prestigious journal The Lancet has published the results of this study, which is the result of more than 20 years of pre-clinical research and 7 years of patient follow-up.

Related professionals

David Ovelleiro Fraile

David Ovelleiro Fraile

Postdoctoral researcher
Peripheral Nervous System
Read more
Agustin Papolla

Agustin Papolla

Predoctoral researcher
Clinical Neuroimmunology
Read more
Julia Basallote Garcia deQuiros

Julia Basallote Garcia deQuiros

Tècnic/a Grau Superior
Pre-Award Project Unit
Competitive Research Directorate
Read more
Candido Diaz Lagares

Candido Diaz Lagares

Postdoctoral researcher
Shock, Organ Dysfunction and Resuscitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.